Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Weiland

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Hepatology (Baltimore, Md.)|August 9, 2020
REPLYHabiba Kamal, Ola Weiland, Soo Aleman
Lakartidningen|June 3, 2009
[Fibrosis indexes reduce the need of liver biopsy in chronic hepatitis C]Johan Björklund, Soo Aleman, Ola Weiland
AIDS (London, England)|April 23, 2008
Similar hepatitis C virus RNA kinetics in HIV/hepatitis C virus monoinfected genotype 2 or 3 matched controls during hepatitis C virus combination therapyOlle Karlström, Anders Sönnerborg, Ola Weiland
Infectious Diseases (London, England)|November 7, 2017
Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a reviewHilmir Asgeirsson, Anders Thalme, Ola Weiland
Medicine|December 9, 2016
Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: Experience from a Swedish referral hospitalHilmir Asgeirsson, Anders Thalme, Ola Weiland
Expert Opinion on Biological Therapy|June 17, 2009
DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving targetMatti Sällberg, Lars Frelin, Ola Weiland
Scandinavian Journal of Gastroenterology|April 28, 2006
Health-related quality of life before, during and after combination therapy with interferon and ribavirin in unselected Swedish patients with chronic hepatitis CAnna Hollander, Graham R Foster, Ola Weiland
Infectious Diseases (London, England)|June 3, 2017
Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange programMartin Kåberg, Anders Hammarberg, Christer Lidman, et al.
Journal of Viral Hepatitis|September 8, 2020
Reduced work absenteeism in patients with hepatitis C treated with second-generation direct-acting antiviralsPeter Lindgren, Sofia Löfvendahl, Gunnar Brådvik, et al.
Scandinavian Journal of Gastroenterology|March 28, 2008
A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical settingPer Sangfelt, Ingrid Uhnoo, Olle Reichard, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Hepatology (Baltimore, Md.)|August 9, 2020
REPLYHabiba Kamal, Ola Weiland, Soo Aleman
Lakartidningen|June 3, 2009
[Fibrosis indexes reduce the need of liver biopsy in chronic hepatitis C]Johan Björklund, Soo Aleman, Ola Weiland
AIDS (London, England)|April 23, 2008
Similar hepatitis C virus RNA kinetics in HIV/hepatitis C virus monoinfected genotype 2 or 3 matched controls during hepatitis C virus combination therapyOlle Karlström, Anders Sönnerborg, Ola Weiland
Infectious Diseases (London, England)|November 7, 2017
Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a reviewHilmir Asgeirsson, Anders Thalme, Ola Weiland
Medicine|December 9, 2016
Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: Experience from a Swedish referral hospitalHilmir Asgeirsson, Anders Thalme, Ola Weiland
Expert Opinion on Biological Therapy|June 17, 2009
DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving targetMatti Sällberg, Lars Frelin, Ola Weiland
Scandinavian Journal of Gastroenterology|April 28, 2006
Health-related quality of life before, during and after combination therapy with interferon and ribavirin in unselected Swedish patients with chronic hepatitis CAnna Hollander, Graham R Foster, Ola Weiland
Infectious Diseases (London, England)|June 3, 2017
Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange programMartin Kåberg, Anders Hammarberg, Christer Lidman, et al.
Journal of Viral Hepatitis|September 8, 2020
Reduced work absenteeism in patients with hepatitis C treated with second-generation direct-acting antiviralsPeter Lindgren, Sofia Löfvendahl, Gunnar Brådvik, et al.
Scandinavian Journal of Gastroenterology|March 28, 2008
A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical settingPer Sangfelt, Ingrid Uhnoo, Olle Reichard, et al.
Pageof 10